Healthcare provider profile · identity verified

Angel E Tafur, MD

Family Practice · THE VILLAGES, FL · NPI 1801892401

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	768	234
Levothyroxine Sodium	Levothyroxine Sodium	519	144
Rosuvastatin Calcium	Rosuvastatin Calcium	408	137
Amlodipine Besylate	Amlodipine Besylate	329	108
Lisinopril	Lisinopril	316	98
Hydrochlorothiazide	Hydrochlorothiazide	267	85
Losartan Potassium	Losartan Potassium	265	86
Montelukast Sodium	Montelukast Sodium	248	93
Omeprazole	Omeprazole	240	71
Metoprolol Tartrate	Metoprolol Tartrate	237	72
Meloxicam	Meloxicam	212	77
Pantoprazole Sodium	Pantoprazole Sodium	208	78
Gabapentin	Gabapentin	181	64
Simvastatin	Simvastatin	181	55
Tamsulosin Hcl	Tamsulosin Hcl	176	55
Metformin Hcl	Metformin Hcl	161	53
Mirtazapine	Mirtazapine	160	50
Metoprolol Succinate	Metoprolol Succinate	155	56
Furosemide	Furosemide	145	55
Allopurinol	Allopurinol	142	40
Eliquis	Apixaban	133	36
Trazodone Hcl	Trazodone Hcl	127	47
Potassium Chloride	Potassium Chloride	109	35
Synthroid	Levothyroxine Sodium	106	30
Buspirone Hcl	Buspirone Hcl	105	44
Fluticasone Propionate	Fluticasone Propionate	98	43
Clopidogrel	Clopidogrel Bisulfate	94	28
Prednisone	Prednisone	88	58
Alendronate Sodium	Alendronate Sodium	87	26
Pravastatin Sodium	Pravastatin Sodium	84	25
Atenolol	Atenolol	82	26
Glipizide Er	Glipizide	79	21
Carvedilol	Carvedilol	77	28
Citalopram Hbr	Citalopram Hydrobromide	77	19
Sertraline Hcl	Sertraline Hcl	76	19
Donepezil Hcl	Donepezil Hcl	75	21
Jardiance	Empagliflozin	70	18
Ezetimibe	Ezetimibe	69	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	66	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	15
Finasteride	Finasteride	57	16
Albuterol Sulfate Hfa	Albuterol Sulfate	56	30
Azithromycin	Azithromycin	53	48
Alprazolam	Alprazolam	52	22
Fenofibrate	Fenofibrate Nanocrystallized	49	17
Doxycycline Hyclate	Doxycycline Hyclate	47	38
Zolpidem Tartrate	Zolpidem Tartrate	47	15
Escitalopram Oxalate	Escitalopram Oxalate	44	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	37
Celecoxib	Celecoxib	41	19
Fenofibrate	Fenofibrate	39	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	39	13
Famotidine	Famotidine	37	11
Hydralazine Hcl	Hydralazine Hcl	36	15
Verapamil Hcl	Verapamil Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	21
Glimepiride	Glimepiride	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Bumetanide	Bumetanide	28	12
Ramipril	Ramipril	28	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Gemfibrozil	Gemfibrozil	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	14
Glipizide	Glipizide	25	12
Latanoprost	Latanoprost	24	suppressed
Spironolactone	Spironolactone	24	12
Duloxetine Hcl	Duloxetine Hcl	23	11
Colesevelam Hcl	Colesevelam Hcl	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Estradiol	Estradiol	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Terazosin Hcl	Terazosin Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Clonidine	Clonidine	16	suppressed
Nebivolol Hcl	Nebivolol Hcl	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Cefdinir	Cefdinir	15	12
Diclofenac Sodium	Diclofenac Sodium	15	11
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Paroxetine Cr	Paroxetine Hcl	15	suppressed
Primidone	Primidone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Combigan	Brimonidine Tartrate/Timolol	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Mupirocin	Mupirocin	13	12
Nifedipine Er	Nifedipine	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Temazepam	Temazepam	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Ozempic	Semaglutide	11	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Roflumilast	Roflumilast	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error